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Repeated cocaine exposure causes persistent, mal-
adaptive alterations in brain and behavior, and hope
for effective therapeutics lies in understanding these
processes. We describe here an essential role for
fragile X mental retardation protein (FMRP), an
RNA-binding protein and regulator of dendritic pro-
tein synthesis, in cocaine conditioned place prefer-
ence, behavioral sensitization, andmotor stereotypy.
Cocaine reward deficits in FMRP-deficientmice stem
from elevated mGluR5 (or GRM5) function, similar to
a subset of fragile X symptoms, and do not extend
to natural reward. We find that FMRP functions
in the adult nucleus accumbens (NAc), a critical
addiction-related brain region, to mediate behavioral
sensitization but not cocaine reward. FMRP-defi-
cient mice also exhibit several abnormalities in NAc
medium spiny neurons, including reduced presynap-
tic function and premature changes in dendritic
morphology and glutamatergic neurotransmission
following repeated cocaine treatment. Together,
our findings reveal FMRP as a critical mediator of
cocaine-induced behavioral and synaptic plasticity.
INTRODUCTION
Recent evidence suggests that exposure to drugs of abuse, as
well as other experiences (e.g., motor learning, novel environ-
ment, and whisker trimming), alter synaptic connectivity by
influencing both the strengthening and formation, as well as
the weakening and elimination, of glutamatergic synapses.
Drug-induced alterations in connectivity are likely important
because they can be long lasting and may underlie aspects ofaddiction-related behaviors (Lee et al., 2006; Li et al., 2004). In
rodent models of drug use, increased dendritic spine density
(Lee et al., 2006; Li et al., 2004; Norrholm et al., 2003; Robinson
and Kolb, 1999) and synaptic strength (Kourrich et al., 2007)
of dopaminoreceptive medium spiny neurons (MSNs) in the
nucleus accumbens (NAc) have been widely reported. The
presence, degree, and longevity of these synaptic changes
appear to depend on several factors such as drug dose, length
of exposure and withdrawal, MSN subtype, and NAc subregion.
However, factors controlling drug-induced synaptic plasticity
remain elusive. Here, we identify a role for the RNA-binding
protein, fragile X mental retardation protein (FMRP), as a key
regulator of synaptic and behavioral alterations following expo-
sure to cocaine (COC).
The molecular and cellular mechanisms that control excitatory
synapse number remain poorly understood. We and others have
reported that the myocyte enhancer factor 2 (MEF2) family of
transcription factors negatively regulates glutamatergic synapse
and dendritic spine number in hippocampal neurons (Flavell
et al., 2006). We extended these findings to the adult NAc in vivo,
showing that MEF2 regulates the dendritic spine density of NAc
MSNs basally and that chronic COC administration can increase
NAc MSN spine density, at least in part, by inhibition of MEF2
(Pulipparacharuvil et al., 2008; Zhang et al., 2012). Most recently,
we reported that MEF2-induced synapse elimination in hippo-
campal neurons requires the RNA-binding capabilities of
FMRP (Pfeiffer et al., 2010) and a complex molecular mechanism
involving the MEF2 target gene, Pcdh10, and targeted degrada-
tion of the synaptic scaffold protein, PSD-95 (Tsai et al., 2012).
FMRP regulates the transport, stability, and/or translation rate
of more than 850 brain mRNAs, many of which are linked to syn-
aptic function (Darnell et al., 2011). Loss of FMRP expression
in humans, as occurs in fragile X syndrome (FXS), results in a
variety of neurological symptoms, including sensory hypersen-
sitivity, intellectual disability, and often, autism-associated be-
haviors and/or epilepsy (for review, see Hagerman, 2006). In
dendrites, FMRP regulates local protein synthesis of associatedNeuron 82, 645–658, May 7, 2014 ª2014 Elsevier Inc. 645
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FMRP and Cocaine-Induced PlasticitymRNAs, at least in part, by stalling translation on polyribosomes
(Ceman et al., 2003; Darnell et al., 2011; Stefani et al., 2004).
Glutamate-dependent activation of group I metabotropic gluta-
mate receptors (mGluR1 and mGluR5 [also known as GRM1
and GRM5]) increases local protein synthesis through transient
dephosphorylation and degradation of FMRP (Ceman et al.,
2003; Nalavadi et al., 2012; Narayanan et al., 2007); so, in part,
FMRP serves as a critical gate to processes downstream of
mGluR5, ensuring that their activation occurs under appropriate
conditions. Several studies have reported an important role for
FMRP in regulating mGluR5-dependent synaptic weakening
(long-term depression; LTD) (Huber et al., 2002; Narayanan
et al., 2007; Weiler and Greenough, 1999), for example, and
proper mGluR5 function is required for several COC-related be-
haviors (Chiamulera et al., 2001; Olsen et al., 2010). As such, we
sought to test whether FMRP regulates COC-induced behavioral
and synaptic plasticity in vivo.
RESULTS
FMRP Is Required for the Development of COC-Induced
Behavioral Sensitization
To test the role of FMRP in behavioral responses to repeated
COC administration, we compared behavioral sensitization in
Fmr1 knockout (KO) mice to wild-type (WT) littermates. Behav-
ioral sensitization results from enduring and functional neuro-
adaptations in the NAc and reward-related circuitry that are
hypothesized to underlie the transition to compulsive drug-
seeking and drug-taking behavior in addiction (Koob and Vol-
kow, 2010). Using either moderate or high doses of COC
(daily intraperitoneal [i.p.] injections at 15 or 30 mg/kg for
7 days), we observed that, while both groups showed sensitiza-
tion to COC, WT mice achieved significantly higher levels of
behavioral sensitization than Fmr1 KO mice (Figures 1A–1D;
see statistics listed in Table S1 available online). It is interesting
that COC injections on the first few days elicited similar locomo-
tor responses in both WT and Fmr1 KO mice, suggesting that
FMRP is not required for initial COC-induced activity or early
sensitization but is required for the mechanisms controlling
maximal motor sensitization after repeated exposures. OnceFigure 1. Impaired COC Sensitization in Fmr1 KO Mice Is Dose-Depen
typical Behaviors
(A) Timeline for 15 mg/kg COC sensitization. d, days.
(B) Fmr1 KOmice show a significant deficit in sensitized locomotion to COC (15mg
(acute) exposure does not differ. Deficits are also present at all COC challenge do
show a trend toward significantly enhanced locomotor activity after SAL injectio
(C) Timeline for 30 mg/kg sensitization. d, days; m, months.
(D) Fmr1 KO mice show deficits in locomotor sensitization to 30 mg/kg COC that
30 mg/kg at 1-week withdrawal and 15 mg/kg at 4 and 10 months cumulative with
daily trial after injection are shown.
(E) Top: composite illustration demonstrating time points (arrows) for stereotyp
sampling method (see Experimental Procedures). sec, seconds; chal, challenge;
(F–H) In (F), averagemedian stereotypy scores are shown forWT and Fmr1 KO litte
Fmr1 KOmice show a significantly higher score after repeated high-dose COC tre
withdrawal. (G) Hand-scored locomotor activity during stereotypy analysis. (H
treatment is largely made up of orofacial behaviors (composite score: paw-to-mou
post hoc tests; column abbreviations denote within-group differences of the labele
#p < 0.10, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001; data shown aredeveloped, reduced sensitized responses in Fmr1 KO mice
were also observed after 3 to 7 days of withdrawal, at several
different COC challenge doses (7.5, 15, and 30 mg/kg; Figures
1B and 1D), and at 4 and 10 total months of withdrawal (Fig-
ure 1D). In contrast, neither the sensitized locomotion to context
alone (saline [SAL]; Figure 1B, ‘‘0’’ challenge) nor the activity dur-
ing noninjection trials (habituation trials in Figures S1A and S1B)
were different between genotypes.
Since the observed group differences could result from
hypersensitivity to COC-induced stereotypy in Fmr1 KO mice,
we used a time-sampling approach (Kelley, 1998) to evaluate
SAL- or COC-induced stereotypy in Fmr1KOandWT littermates,
scoring behaviors both individually and on a published scale
(Spangler et al., 1997). While WT and Fmr1 KO littermates did
not differ after repeated SAL or acute, high-dose COC (30 mg/
kg) on any stereotypy-related assessments, Fmr1 KO mice
showed significantly greater stereotypy after repeated high-
dose COC (Figure 1F, ‘‘Repeated’’; for matching locomotion,
see Figures 1G and S1E). More detailed analysis showed that
the heightened stereotypy involved primarily orofacial behaviors
(i.e., taffy pulling and paws to mouth; Figure 1H), but not groom-
ing- or sniffing-related activities (Figures S1F and S1G). In con-
trast, stereotypy was not heightened in Fmr1 KO mice following
a lower dose challenge (15 mg/kg; Figure 1F, ‘‘Challenge’’),
even though locomotor activity remained significantly impaired
(last challenge in Figure 1D). To determine whether the increase
in stereotypy at 30 mg/kg could reflect a general hypersensi-
tivity to COC in Fmr1 KO mice, we also assessed sensitization
using two lower doses of COC (5 and 10 mg/kg). While both
genotypes sensitized to each dose, there were no locomotor
differences between the groups (Figures S1C and S1D), indi-
cating that Fmr1 KO mice are not hypersensitive to COC in
general. Together, these data suggest that loss of FMRP impairs
behavioral sensitization at moderate COC doses but enhances
the development of stereotypy at higher COC doses.
Deficits in the cyclic AMP (cAMP) signaling cascade have
previously been shown in Fmr1 KO mice (Wang et al., 2008),
which could be relevant to our observations regarding sensiti-
zation. To address this possibility, we examined phosphoryla-
tion of the serine-845 site of glutamate receptor 1 (GluA1), adently Associated with Reduced Locomotion and Enhanced Stereo-
/kg) compared toWT littermates (n = 13WT, 11 KO), while activity after the first
ses—15, 7.5, and 30 mg/kg—but not at the SAL challenge. Fmr1 KOmice also
ns.
are not present acutely and that extend to challenges at different time points:
drawal (n = 12WT, 12 KO). Cumulative beam breaks for the first 20 min of each
y analysis after injection. Bottom: arrows and boxes illustrate example time
min, minute.
rmates using amodified scale (Spangler et al., 1997) (OS, orofacial stereotypy).
atment (n = 12 KO, 12 WT) but not after a lower dose challenge after long-term
) The increased stereotypy observed in Fmr1 KO mice after repeated COC
thmovements + taffy pulling). Asterisks refer to significant follow-up Bonferroni
d bar compared to noted day (S4, SAL Day 4; C1, COCDay 1; C4, COCDay 4).
mean ± SEM. See also Figure S1 and Table S1.
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Figure 2. FMRP-Deficient Mice Have COC
Reward Deficits that Relate to mGluR5
Hyperactivity and Not to General Deficits
in Natural Reward Processes or Learning/
Memory
(A) Timeline for CPP. C, COC; S, SAL; Pre, pretest;
post, posttest.
(B) Fmr1 KO mice show significantly decreased
preference for a COC-paired context (7.5 mg/kg;
n = 11 WT, 12 KO). sec, seconds.
(C) Assessment of learning and memory in Fmr1
KO andWTmice using fear conditioning shows no
differences in training or in contextual or cued
testing (n = 11 KO, 12 WT). ns, not significant.
(D) Timeline for food CPP. HF, = high fat; RC,
regular chow.
(E) Fmr1 KO and WT littermates show comparable
preference for high-fat (HF) chow (n = 16 KO, 15
WT). reg, regular.
(F) They also do not differ in two-bottle choice
preference for sucrose (n = 10 KO, 10 WT).
(G) Compound mutant littermates show that
impaired CPP in total Fmr1 KO mice is rescued by
a reduction in themGluR5 receptor (n = 29WT/WT,
27 HET/WT, 22 WT/KO, 27 HET/KO). Asterisk
indicates significant follow-up Bonferroni post hoc
test. HET, heterozygous.
*p < 0.05 and **p < 0.01; data shown are mean ±
SEM. See also Figure S2 and Table S1.
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FMRP and Cocaine-Induced Plasticitydownstream target of this cascade, in Fmr1 KO and WT litter-
mates after a COC dosing regimen similar to that used for sensi-
tization testing. We observed a similar induction of P-S845 levels
in WT and KO mice striata after acute or chronic COC dosing
(Figure S1H), suggesting that a deficit in COC-induced activation
of cAMP/protein kinase A-dependent signaling in the striatum
is unlikely to account for the behavioral alterations that we
observed.648 Neuron 82, 645–658, May 7, 2014 ª2014 Elsevier Inc.FMRP Is Required for the
Development of COC-Related
Reward Learning
To test whether FMRP influences other
types of COC-induced behaviors, we
examined COC reward in a naive cohort
of WT and Fmr1 KO mice using the COC
conditioned place preference (CPP)
assay. In this assay, mice are injected
with either COC (7.5 mg/kg) or SAL and
placed in one of two contextually distinct
chambers on conditioning days. On pre-
and posttest days, mice are placed into
the center chamber and allowed to freely
explore all three chambers for 20min, and
time spent in the COC-paired chamber
minus time spent in the SAL-paired
chamber is defined as COC preference.
Similar to the locomotor sensitization
results, we observed a significant reduc-
tion in preference for the COC-paired
chamber in Fmr1 KO mice (Figure 2B),suggesting that FMRP is required for COC reward and/or
learning and memory of context-drug associations. Similar to
the behavioral sensitization findings, the COC reward deficit
disappeared at a lower dose (5 mg/kg), where both WT and
KO mice showed reduced, but comparable, preference for the
drug-paired chamber (Figure S2A). Consistent with demons-
tration of normal reward learning at lower doses of COC, we
observed that Fmr1 KO mice showed normal context- and
Neuron
FMRP and Cocaine-Induced Plasticitycue-induced freezing at 24 hr after receiving three mild, aversive
foot shocks in the standard fear conditioning assay (Figures 2C
and S2B), suggesting that Fmr1 KO mice are able to remember
a salient stimulus-context association in a timeframe similar to
that used in the COC CPP assay.
Given that Fmr1 KO mice model a clinical condition, FXS, we
next asked whether deficits in COC reward behaviors would
extend to natural reward, which would have important implica-
tions for this patient population. To assess this possibility, we
used the same COC CPP chambers to test WT and Fmr1 KO
mice for palatable food-based CPP. Both genotypes showed
equivalent preference for high-fat chow compared to regular
chow (Figures 2D and 2E). Similarly, we observed no genotype
differences in the preference for sucrose at multiple concentra-
tions (Figures 2F and S2C) in the standard two-bottle choice
test. Together, these results suggest that FMRP is not required
for all reward-related behaviors and may be more specific to
drug reward behavior.
A number of FXS-related phenotypes have now been attrib-
uted to hyperactivity or hypersensitivity of mGluR5 (Do¨len
et al., 2007), and manipulating mGluR5 activity has been shown
to alter drug reward behaviors (Olive, 2009; Rutten et al., 2011).
Therefore, we used a gene dosage approach to test whether
mGluR5 hyperfunction might contribute to the observed
deficit in COC reward behavior in Fmr1 KO mice. While mice
lacking one copy of the mGluR5 gene (mGluR5+/) had normal
COC reward learning behavior, reducing mGluR5 levels did
rescue the Fmr1 KO deficit (Figure 2G), suggesting that Fmr1
KO impairments in COC CPP stem from mGluR5 hyperactivity.
Taken together, these results suggest that mice lacking FMRP
have reduced sensitivity to the rewarding impact of moderate
dose COC.
FMRP Is Required in the Adult NAc for Behavioral
Sensitization but Not Drug Reward
In the adult brain, the NAc is a critical brain region for the devel-
opment and expression of COC reward and behavioral sensitiza-
tion. Fmr1/FMRP is expressed in the adult NAc (Allen Institute for
Brain Science, 2014; Figures S3C and S3D). To test whether
FMRP in the adult NAc is required for the rewarding and behav-
ioral effects of repeated COC administration, we performed
bilateral injections of AAV2-Cre-GFP or AAV2-GFP control vi-
ruses in the NAc of adult floxed Fmr1 mutant mice (Mientjes
et al., 2006) to generate conditional KO of Fmr1 (NAc cKO) in
the adult brain (Figure 3A). The Fmr1 NAc cKO and control
mice were then tested for COC reward and behavioral sensitiza-
tion, as indicated (Figure 3B). Neither conditional NAc deletion
of Fmr1 (Figure 3C) nor conditional deletion of Fmr1 in dopami-
nergic neurons (DAT-Cre:Fmr1fl/y; Figure S3A), caused a sig-
nificant deficit in COC reward behavior, suggesting that the
observed COC reward deficit in Fmr1 KO mice is due to a role
for FMRP in additional brain region(s) and/or to a developmental
role for FMRP. In contrast, the Fmr1 NAc cKO mice showed a
significant reduction in COC-induced behavioral sensitization
(Figures 3D and S3B) reminiscent of the effect observed in
Fmr1 total KO mice after repeated COC exposure, suggesting
strongly that FMRP plays an active role in the adult NAc to
mediate the plasticity underlying behavioral sensitization.In contrast to other factors implicated in COC-induced behav-
ioral plasticity that appear to be regulated by COC (e.g., DFosB),
we did not observe any evidence that FMRP mRNA or protein
levels were altered by repeated COC administration at 24 hr
after the last injection of either 15 or 30 mg/kg (Figures S3C
and S3D). These findings indicate that FMRP’s function in medi-
ating the normal development of behavioral sensitization does
not likely involve changes in its basal levels. Taken together,
our combined data suggest that FMRP functions in the adult
NAc to mediate behavioral plasticity induced by repeated,
moderate-to-high dose COC, but its role in COC reward
behavior is more complex.
FMRP Limits COC-Induced Increases in Structural
Alterations in the NAc
Numerous studies have reported that repeated, high-dose COC
exposure induces structural and synaptic plasticity in MSNs of
the NAc, and some of these changes have been proposed to
support or antagonize COC behaviors. FMRP is known to regu-
late synapse weakening and to promote dendritic spine and
excitatory synapse elimination (Pfeiffer et al., 2010; Weiler and
Greenough, 1999), as well as to control proper dendritic branch
extension and pruning (Thomas et al., 2008). To explore FMRP’s
role in repeated COC-induced structural plasticity in the NAc, we
injected WT and Fmr1 KO mice with repeated daily COC or SAL
in the same manner as described previously (i.e., 15 mg/kg daily
COC injections 3 7 days; Figure 4A). We analyzed MSNs 24 hr
after the last injection since (1) maximal behavioral sensitization
has been fully established by this time, (2) behavioral sensitiza-
tion differences between WT and Fmr1 KO mice are established
and persistent through short- or long-term withdrawal, and (3)
any relevant structural or functional changes in the NAc that
regulate behavioral sensitization must also be present. Using a
well-establishedGolgi staining procedure, we used stereomicro-
scopy to reconstruct MSNs from the NAc core or shell regions
(Figure 4B). In the core subregion of Fmr1 KOmice, we observed
that repeated COC exposure induced a significant increase in
the number and total length of dendritic branches (Figures 4C
and 4D). In contrast, no significant changes were observed in
shell MSN dendritic branching morphology for WT or Fmr1 KO
mice after repeated COC exposure (Figures S4A and S4B).
We next analyzed dendritic spine density in core and shell
MSNs in both WT and Fmr1 KO mice. In the core, we observed
no alterations in dendritic spine density in WT or KO mice after
repeated COC administration; however, there was a modest
increase in overall core MSN spine density in Fmr1 KO mice
compared to WT (Figure S4C, inset), which reached significance
for the thin spine category (Figure S4C). Similar to the core, we
observed noCOC-induced changes in overall net dendritic spine
density in shell MSNs from WT mice (Figure 4E, inset). While
others, including our group, have observed COC-induced
changes in this region, we note that most published studies
have used higher doses of COC (20–30 mg/kg COC) and longer
administrations. In contrast to the WT littermates, repeated COC
exposure did significantly increase overall shell MSN spine den-
sity in Fmr1 KO mice (Figure 4E, inset). Closer examination re-
vealed that thin and stubby spine subtypes were increased after
COC treatment in Fmr1 KO mice, whereas no spine subtypesNeuron 82, 645–658, May 7, 2014 ª2014 Elsevier Inc. 649
Figure 3. FMRP in the Adult NAc Is Required for Normal Behavioral Sensitization to COC
(A) Example intra-NAc stereotaxic injection with respect to the mouse brain atlas (bregma, 0.98 mm) (Paxinos and Franklin, 2001). LV, lateral ventricle; aca,
anterior commissure.
(B) Timeline for viral stereotaxic surgery and testing. C, COC treatment; S, SAL treatment; pre, pretest; post, posttest; d, days.
(C) Loss of NAc FMRP does not recapitulate the reduction in CPP observed in total Fmr1 KOmice (7.5mg/kg; n = 18 AAV-CRE-GFP, 22 AAV-GFP). sec, seconds.
(D) Floxed-Fmr1 conditional KO mice injected with AAV-CRE-GFP show a significant deficit in COC sensitization (15 mg/kg) compared to those injected with
AAV-GFP, which is not significant at acute exposure (n = 18 AAV-CRE-GFP, 22 AAV-GFP). Cumulative beam breaks for the first 20 min of each daily trial after
injection are shown.
ns, not significant; **p < 0.01. Data shown are mean ± SEM. See also Figure S3 and Table S1.
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FMRP and Cocaine-Induced Plasticitywere altered by COC in WT mice. Together, these findings sug-
gest that FMRP normally functions to antagonize the formation of
NAc dendritic spines and branching in response to COC expo-
sure, which is consistent with its known role as a mediator of
dendritic pruning and spine elimination (Pfeiffer et al., 2010;
Weiler and Greenough, 1999). The findings reveal that an overall
increase in NAc core or shell MSN spine density is not strictly650 Neuron 82, 645–658, May 7, 2014 ª2014 Elsevier Inc.required for the development and short-term expression of
behavioral sensitization. Moreover, the precocious increase in
dendritic spine density in NAc shell in the Fmr1 KO mice after
repeated COC exposure correlates with a decrease in sensitized
locomotion after short-term withdrawal, similar to several other
reports (LaPlant et al., 2010; Norrholm et al., 2003; Pulippara-
charuvil et al., 2008).
Neuron
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Function in the NAc Shell
We next investigated the role of FMRP in regulating synaptic
transmission in NAc shell MSNs by measuring miniature excit-
atory postsynaptic currents (mEPSCs) under the same condi-
tions used to analyze behavioral sensitization and dendritic
spine density. Consistentwith our shell spine analysis (Figure 4E),
we failed to observe an effect of repeated COC on the mEPSC
frequency in WT mice. However, similar to the dendritic spine
observations, we found that repeated COC administration signif-
icantly increasedmEPSC frequency in Fmr1KOmice (Figure 5A).
Paired-pulse ratio (PPR) in Fmr1 KO mice was not significantly
altered by repeated COC exposure (Figure 5B), suggesting that
the observed increase in mEPSC frequency is likely due to an in-
crease in dendritic spine synapses. Notably, we also observed
that the mEPSC frequency was reduced in SAL-treated Fmr1
KO mice when compared to SAL-treated WT mice, suggesting
a basal decrease in functional synapse number (e.g., as noted
for stubby spine density; Figure 4E) and/or a deficit in presynap-
tic function in the Fmr1 KO mice. Indeed, when we measured
PPRs from WT and Fmr1 KO mice (Figure 5B; Figures S5A and
S5B), Fmr1 KO mice showed an increased ratio, indicating a
deficit in presynaptic release on to NAc shell MSNs compared
to WT mice (Figure 5B).
Recent evidence also demonstrates that repeated COC
administration alters postsynaptic function by increasing
a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid recep-
tor (AMPAR) surface expression. To assess the effects of COC
on postsynaptic AMPAR function in WT and Fmr1 KO mice, we
measured and analyzed mEPSC amplitudes (Figure 5D). It is
interesting that chronic COC significantly increased mEPSC
amplitude in the Fmr1 KO MSNs but had no effect on mEPSC
amplitude in WT MSNs at the 24 hr withdrawal time point.
To gain additional confidence regarding the role of AMPAR-
mediated transmission in the COC-induced increase in mEPSC
amplitude in Fmr1 KO mice, we examined the ratio of AMPARs
to N-methyl-D-aspartate receptors (NMDARs) in KO shell
MSNs at this same time point (Figure 5E). As expected, COC
treatment increased the AMPAR/NMDAR ratio in Fmr1 KO
mice. These findings suggest that FMRP antagonizes both net
spine density increases and AMPAR-mediated synaptic trans-
mission in the NAc shell in response to chronic COC and that,
in WT mice, cellular mechanisms that promote synapse
strengthening and synaptogenesis are equally balanced, at least
at this COC dose and time point, by synapse weakening and
elimination processes that require FMRP.
DISCUSSION
Chronic exposure to drugs of abuse induces changes in synapse
structure and function that are thought to underlie addiction-
related behavioral plasticity. However, the cellular andmolecular
mechanisms that mediate behaviorally relevant plasticity in brain
reward circuitry remain poorly understood. We show here that
FMRP, an RNA binding protein that regulates dendritic pruning
and synapse weakening/elimination, regulates these processes
in NAc core and shell MSNs after COC exposure and is critically
involved in the development of multiple COC-induced behaviors.Specifically, loss of FMRP impairs both COC-induced reward
and behavioral sensitization, apparently via its function in multi-
ple, possibly distinct, brain regions. While FMRP is required
acutely in the adult NAc for the development of behavioral sensi-
tization, its absence either in the NAc or in dopaminergic neurons
is not sufficient to impair COC reward. Instead, deficiencies in
drug-induced reward appear to relate to general hyperactivity
of mGluR5 function in Fmr1 KO mice, since genetic reduction
of mGluR5 expression rescues this deficit. In FMRP-deficient
mice, a sensitizing regimen of COC induces significant changes
in NAc shell and core MSNs that are observable 24 hr after the
last exposure. Without FMRP, repeated COC exposure
increases the number of structural and functional synapses
and synaptic strength of NAc shell MSNs, while core MSNs
undergo COC-induced increases in dendritic branching and
length. In contrast, despite robust behavioral sensitization,
COC-induced changes in net NAc spine density and synaptic
strength are not observed in WT mice at this time point and
COC dose, suggesting that these changes, at least on the global
NAc MSN population, are not required for the development and
short-term expression of behavioral sensitization. In the process
of describing FMRP’s role in COC-induced behavioral and syn-
aptic plasticity, we also add to a small, but growing, literature
defining striatal abnormalities in FXS and reveal, in a unique
setting, how experience-dependent synaptic plasticity goes
awry in its absence—observations that may have relevance to
FXS-associated motor, learning, and behavioral abnormalities.
Our findings with regard to COC reward in Fmr1 KO mice are
intriguing for several reasons. First, our mGluR5 genetic rescue
study suggests that the reduced COC reward behavior in the
Fmr1 KO mice is a result, at least in part, of elevated mGluR5
levels or function, a well-described feature of FXS (Bear et al.,
2004; Osterweil et al., 2010). Genetic/pharmaceutical reduction
of mGluR5 expression/activity reverses most, but not all, of the
observed morphological, behavioral, and functional plasticity
deficits in FXS (Do¨len et al., 2007; Pop et al., 2014); here, we
find that it also rescues COC reward dysfunction in Fmr1 KO
mice. Of note, mGluR5 antagonists are also being explored as
potential therapeutics for addiction based on their ability to
reduce drug-motivated behaviors such as CPP (for review, see
Olive, 2009), although it is not yet clear whether they achieve
this effect by reducing reward sensitivity or via reward substitu-
tion (Rutten et al., 2011). Our findings that reducing mGluR5
levels in the Fmr1 KO restores normal COC reward behavior
suggest that mGluR5’s regulation of COC reward is nonlinear,
so that too much, too little, or constitutive mGluR5 activity might
alter drug reward sensitivity.
Given that FXS is associated with intellectual impairment in
human patients and mice, we tested whether the COC reward
deficit was a result of reduced learning/memory. However,
Fmr1 KO mice made normal contextual associations with both
mildly aversive and naturally rewarding stimuli, as well as with
a lower dose of COC (i.e., 5 mg/kg). These findings are in general
agreement with several other studies showing little or no learning
impairments in Fmr1KOmice on the C57BL/6 background (Dob-
kin et al., 2000; Paradee et al., 1999) and suggest that deficits
in COC reward are not due to general defects in contextual
learning. A second implication from our findings concerns theNeuron 82, 645–658, May 7, 2014 ª2014 Elsevier Inc. 651
(legend on next page)
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observe evidence for reduced natural reward in Fmr1 KO mice,
at least with respect to food-based incentives; however, analysis
of other types of reward deficits that have relevance to FXS, such
as social reward, will be important to explore in the future.
Our close examination of behavioral sensitization in Fmr1 KO
mice highlights the complex interrelationship between COC-
induced locomotor sensitization and motor stereotypies. Since
deficits in sensitized locomotion only became apparent in
Fmr1 KO mice at higher doses (15 and 30 mg/kg) of COC and
only after repeated exposures, we suspected that the reduced
activity in Fmr1 KO mice could be a result of enhanced stereo-
typy behavior competing with locomotion. Indeed, the decrease
in locomotion seen over daily repeated high doses of COC
(30 mg/kg) in both genotypes is almost certainly a result of
competing stereotypy that develops over several days of drug
exposure, and at this high dose, Fmr1 KO mice develop
enhanced stereotypy behavior more rapidly and/or to a greater
extent than WT mice. However, increased stereotypy in Fmr1
KOmice was only observed at the highest dose (30 mg/kg), sug-
gesting that the reduction in locomotion observed at 15 mg/kg is
not a result of potentiated stereotypy. Furthermore, at lower
doses of COC (5 and 10 mg/kg), Fmr1 KO mice show a similar
development of behavioral sensitization to WT mice, arguing
against a general hypersensitivity to COC that reduces locomo-
tion at the 15mg/kg COCdose. Together, these findings suggest
that FMRP contributes to the normal development of both
sensitized locomotion and stereotypy behaviors but in a dose-
sensitive manner. Previous studies have primarily attributed
locomotor activation to the ventral striatum (including the NAc)
and the development of stereotypy to the dorsal striatum (Joyce
and Iversen, 1984); therefore, it seems likely that FMRP is regu-
lating the development of sensitized locomotion in the NAc,
consistent with our conditional Fmr1 KO data (Figure 3D), but
regulating the development of motor stereotypies in the dorsal
striatum (or other regions). Notably, heightened repetitive or ste-
reotypical behaviors are a central feature of FXS and, more
broadly, of autism spectrum disorders. While we did not observe
COC-independent differences in stereotypy between WT and
KO mice, it is interesting to speculate that the enhanced COC-
induced stereotypy behavior in Fmr1KOmice results from subtle
dysfunction in the striatal circuit that regulates repetitive motor
behaviors. In the future, it will be interesting to examine howFigure 4. FMRP Opposes COC-Induced Changes in Dendritic Branch M
(A) Timeline for NAc shell and core MSN dendritic analyses. sac, sacrifice.
(B) Example MSN tracings and focused image stacks of spines from each group
(C) COC treatment significantly increased core MSN second-, third-, and fourth-o
significantly more third- and fourth-order branches than WT MSNs after COC, b
22 KO COC). Symbols indicate significant simple main effects of genotype (u) a
(D) In keeping, the total length of third- and fourth-order core MSN branches was i
was increased in KO compared to WT MSNs after COC but not SAL. Symbols in
(E) An increase in overall spine density of NAc shell MSNs was seen in Fmr1 KOm
decrease in KOSAL stubby spine density compared toWTSAL, accompanied by
toWT SAL-treatedmice. COC treatment increased both stubby and thin spine den
a low basal density of stubby spines in Fmr1 KOmice to no different than in either
Asterisks refer to significant follow-up univariate ANOVAs. Focused images were
(http://imagej.nih.gov/ij/).
Scale bar, 50 mm. #p < 0.10, *p < 0.05, **p < 0.01, and ***p < 0.001; ns, not signithe role and regulation of FMRP in striatal subregions affect mo-
tor stereotypies.
Abnormalities in dendritic morphology have been repeatedly
observed in both patients and animal models of FXS, including
increased basal densities of (especially immature) dendritic
spines (Hinton et al., 1991; Irwin et al., 2000, 2001, 2002; Kooy,
2003; Liu et al., 2011) and altered dendritic branch number and
length (Guo et al., 2011; Lee et al., 2003; Restivo et al., 2005).
However, basal spine density in FXS has, thus far, largely been
studied in the cerebral cortex and hippocampus. We report
here that FMRP-deficient MSNs, which are GABAergic projec-
tion neurons, show no basal spine density alterations in the
NAc shell and only a very small increase in the NAc core. While
FMRP’s spine-regulating function in MSNs could be distinct
from its role in pyramidal glutamatergic neurons, we also reason
that basal spine density may be altered by resting-state activity
in different brain regions. Many of FMRP’s functions are activity
dependent, including dendritic transport (Dictenberg et al.,
2008), spine/synapse elimination (Pfeiffer et al., 2010), and LTD
(Huber et al., 2002), and NAc MSNs have a highly negative
resting membrane potential and require strong afferent activity
to reach spike threshold (Pennartz et al., 1994). Despite the
lack of strong basal differences in WT and Fmr1 KO MSNs,
when a moderate, sensitizing regimen of COC is given, we see
that FMRP-deficient mice produce what appear to be preco-
cious net increases in branching and structural and functional
synapse number, as well as synaptic strength. Specifically, we
observed increases in thin and stubby spine subtypes in the
NAc shell of Fmr1 KO mice at this short, 24 hr withdrawal time
point, the same spine subtypes observed to be increased in
WT rats after 2 weeks of withdrawal from similar COC exposure
(Wang et al., 2013). Even though dendritic spine density did
not change in the NAc core MSNs after COC exposure, we
note that the increase in branch complexity and length may
translate to an overall increase in core dendritic spine number
as well. Similarly, the increases in synaptic strength (i.e., mEPSC
amplitude and AMPA/NMDA receptor ratio) that were observed
in NAc shell MSNs of Fmr1 KO mice after COC exposure are
highly reminiscent of those typically observed in WT rodents
after longer term (i.e., 7- to 21-day) COC withdrawal (Boudreau
and Wolf, 2005; Kourrich et al., 2007).
The functional relevance of these precocious synapse-related
changes in Fmr1 KO mice is intriguing since the WT, littermateorphology and Structural Synapse Number
.
rder branches in Fmr1 KO mice but not in WT littermates. Also, KO MSNs had
ut not SAL treatment (number of cells = 22 WT SAL; 23 WT COC; 22 KO SAL;
nd treatment (d).
ncreased by COC in Fmr1 KO, but not WTmice, and fourth-order branch length
dicate significant simple main effects of genotype (u) and treatment (d).
ice, but not WTmice, after COC (inset). Analysis by spine type revealed a basal
a strong trend toward a significant increase in branched spines in KO compared
sities in KOmice compared to SAL treatment. While COC treatment ‘‘rescued’’
WT group, thin spine density was significantly elevated above that of WT COC.
created using an ImageJ Extended Depth of Field plug-in (Aguet et al., 2008)
ficant. Data shown are mean ± SEM. See also Figure S4 and Table S1.
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Figure 5. FMRP Opposes COC-Induced
Changes in Functional Synapse Number
and Synaptic Strength
(A) Similar to observations for overall spine
density, the frequency of mEPSC events was
observed to be uniquely susceptible to COC
treatment (5 days [d], 15mg/kg + 24 hr) in Fmr1KO
mice (number of cells = 11 KO SAL treatment,
16 KO COC, 13 WT SAL, 15 WT COC). Addition-
ally, a significant basal decrease in mEPSC fre-
quency was present in Fmr1 KO compared to WT
mice (planned comparison).
(B) Increased PPR (i.e., decreased presynaptic
release) was seen in Fmr1 KO mice compared to
WT mice (interstimulus interval = 100 ms; number
of cells = 9 KO SAL, 14 KO COC, 7 WT SAL, 11
WT COC). A trend was also present for COC to
decrease presynaptic release across genotypes.
(C) Representative traces of mEPSCs from each
group.
(D) An overall significant interaction was observed
for mEPSC amplitude, which was uniquely
increased by COC treatment in Fmr1 KO mice;
among COC-treated mice only, KO had higher
amplitude than WT.
(E) COC treatment also increased the AMPAR/
NMDAR ratio in Fmr1 KOMSNs (number of cells =
7 SAL treatment, 11 COC).
Asterisks in (A) and (D) indicate significant follow-
up Bonferroni post hoc tests, except planned
comparison (independent samples t test). Scale
bar, 10 pA/100 ms. *p < 0.05 and **p < 0.01. Data
shown are mean ± SEM. See also Figure S5 and
Table S1.
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the NAc shell (or structural in core), despite developing robust
behavioral sensitization. Whether and how COC-induced spine
density—in particular, in the NAc—is related to drug-induced
behaviors, especially behavioral sensitization and COC reward,
remain long-standing and largely unresolved questions in the
addiction field (Rothenfluh and Cowan, 2013; Russo et al.,
2010). A number of previous studies, including one from our
own lab, reported molecular or genetic manipulations that
regulated COC-induced dendritic spine density and behavioral
sensitization. While some inversely alter (LaPlant et al., 2010;
Norrholm et al., 2003; Taylor et al., 2007; Waselus et al., 2013)
or even dissociate the two (Kiraly et al., 2010; Pulipparacharuvil
et al., 2008; Wang et al., 2013), other manipulations positively
regulate both spines and behavior (Dietz et al., 2012; Kelz
et al., 1999; Maze et al., 2010). Similar to the Dnmt3a KO mice
(LaPlant et al., 2010), Fmr1 KO mice show a selective increase654 Neuron 82, 645–658, May 7, 2014 ª2014 Elsevier Inc.in ‘‘thin’’ dendritic spines after COC
treatment compared to WT mice, and in
both studies, this increase is associated
with reduced behavioral sensitization.
However, in all of the studies on this sub-
ject, the primary manipulation is specif-
ically on the molecule/gene, which can
have many cellular functions that influ-
ence behavioral sensitization indepen-dent of COC-induced changes in dendritic spines. Similar to
our current findings, a recent report suggests that the dendritic
spine density increase is not required for behavioral sensitization
but does underlie incentive sensitization (Wang et al., 2013), a
process whereby COC experience increases later sensitivity to
COC reward. A relationship between COC-induced alterations
in NAc spine density and CPP has also been proposed (Dietz
et al., 2012; Marie et al., 2012; Maze et al., 2010; Russo et al.,
2009). While we did not specifically look at dendritic spine den-
sity changes in WT or Fmr1 KOmice under COC CPP conditions
(e.g., 7.5 mg/kg COC 3 2 injections), we suspect that changes
in WT mice would not be observed under these low-dose condi-
tions; however, in the future, it will be important to test this idea
more directly.
The lack of change in the AMPAR-mediated synaptic trans-
mission of our WT mice treated with COC is consistent with pre-
vious studies showing that repeated daily COC administration
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FMRP and Cocaine-Induced Plasticitydoes not increase overall NAc glutamatergic synaptic strength
(synaptic AMPAR surface expression or AMPA/NMDA receptor
ratio) in WT mice after short-term (i.e., 1 day) withdrawal (Bou-
dreau and Wolf, 2005; Kourrich et al., 2007) and supports the
idea that global changes in overall NAc glutamatergic synapse
strength are not required for the short-term expression of
behavioral sensitization (Boudreau et al., 2007). Instead, time-
dependent increases in synaptic potentiation have been sug-
gested to promote withdrawal-associated behaviors, such as
incubation of drug craving (Conrad et al., 2008), as well as
withdrawal-dependent locomotor sensitization after a single
previous exposure (Pascoli et al., 2012); therefore, it may be
important to investigate such behaviors in the Fmr1 KO mice in
the future. Also, recent studies report that repeated COC expo-
sure triggers the generation of transient, silent synapses in the
NAc after short-term withdrawal (Huang et al., 2009; Koya
et al., 2012). It will be interesting to determine if FMRP contrib-
utes to the generation or duration of silent synapses in the future.
One interesting finding in our study is basal reduction in
presynaptic function of glutamatergic inputs on to NAc shell
MSNs in Fmr1 KOmice. While its presynaptic role is not well un-
derstood, FMRP is present in axons, including in presynaptic
compartments, particularly in neurons undergoing high levels
of activity-dependent plasticity, such as that seen during brain
development, reinnervation after injury, and adult neurogenesis
(Akins et al., 2009; Christie et al., 2009). FMRP binds approxi-
mately one third of the mRNAs known to encode proteins in
the mouse presynaptic proteome (Darnell et al., 2011). COC
CPPwas normal when FMRPwas selectively deleted from either
the adult NAc or in all dopamine-transporter-expressing, dopa-
minergic neurons, suggesting that loss of presynaptic FMRP in
NAc afferents, during either development or adulthood, might
contribute to the COC reward deficit in the Fmr1 KO mouse.
However, it is not yet clear whether or how the observed presyn-
aptic function deficit in naive Fmr1 KO mice affects any of the
observed behavioral or synaptic plasticity changes seen after
COC administration. It will be interesting to investigate the po-
tential contribution of presynaptic alterations in FMRP-deficient
mice in the COC-induced behavioral and synaptic changes in
future studies.
Overall, our data reveal an essential role for FMRP in the adult
NAc to facilitate behavioral plasticity to repeated COC exposure,
possibly via its negative regulation of MSN structural and
functional synapse number and strength during repeated COC
exposure. Through this process, we help to elucidate FMRP’s
role in the ventral striatum and how its absence alters experi-
ence-driven plasticity, which has implications for understanding
the abnormal brain function and plasticity that contribute to
symptoms of FXS. Our findings suggest that FMRP-dependent
synapse weakening and elimination are important for the devel-
opment of repeated COC-induced behavioral plasticity and
reveal an important role for FMRP or one of its regulated
processes (local protein synthesis, dendritic RNA trafficking,
AMPAR endocytosis and LTD, MEF2-dependent synapse
elimination, etc.) in the establishment of stable drug-induced be-
haviors. As such, FMRP or one of its associated and regulated
mRNAs, may be a desirable therapeutic target for the treatment
of drug addiction.EXPERIMENTAL PROCEDURES
Detailed methods are given in the Supplemental Experimental Procedures.
Animals and Drugs
Experimental procedures were approved by Institutional Animal Care and Use
Committees at the University of Texas Southwestern Medical Center, McLean
Hospital, or the University of Minnesota. COCHCl was dissolved in 0.9%NaCl
(vehicle).
Locomotor Sensitization
Activity was collected via photobeam arrays (San Diego Instruments) before
and after injection. Mice received SAL for 3–4 days and COC (5, 10, 15, or
30 mg/kg) for the next 7 days. After 1 (10, 15, and 30 mg/kg) or 2 weeks
(5mg/kg), a same-dose COC challenge was given, followed by additional chal-
lenges (see timelines in Figures 1A, 1C, and 3B; Supplemental Experimental
Procedures). Data shown are the sum of total beam breaks over the first
20 or 30 min of each trial.
Stereotypy Analysis
During the indicated locomotor trials, mouse behavior was scored at regular
intervals for 30 min after injection using a published scale (Spangler et al.,
1997), and for specific behaviors (e.g., taffy pulling). Median scores (scale) or
individual behavior sums for each mouse across the trial were used to calcu-
late group averages.
COC CPP
CPP (unbiased) consisted of a pretest, four alternating COC or SAL condition-
ing sessions, and a posttest, conducted on separate days. Food CPP was
similar, except there were 12 alternating high-fat or regular chow conditioning
sessions. Data are expressed as time in the reward-paired chamber minus
time in the control-paired chamber during the posttest.
Fear Conditioning
Fear conditioning consisted of three 30 s tones that coterminated with a two-
sec (0.5 mA) shock (training). On subsequent days, mice were re-exposed to
the same context (contextual test) and to the tone in a new context (cued
test). Freezing was hand scored by an observer blind to genotype.
Sucrose Preference
After acclimation, individually housed mice were given four 24-hr periods of
access to water and 1% sucrose in identical sipper tubes (test). Additional
tests (4% and 0.5%) were performed after short periods of normal water
access.
Stereotaxic Surgery
Anesthetized floxed Fmr1mice received either AAV2-GFP or AAV2-CRE-GFP
(1 ml per hemisphere; Vector Biolabs) bilaterally to the NAc (dorsal-ventral
4.4, medial-lateral +1.5, anterior-posterior +1.6). CPP began 20–21 days
after surgery (Figure 3B).
Tissue Collection and Processing
Bilateral NAc and dorsal striata were individually dissected from coronal
sections and processed by hemisphere for RT-PCR (Hale et al., 2011) or
western blotting. For Golgi staining, brains were processed according to
the manufacturer (FD Neurotechnologies), sliced (150 mm), and mounted.
For immunohistochemistry, anesthetized mice were perfused intracardially
with PBS and 4% paraformaldehyde. Brains were postfixed, cryoprotected,
and sectioned (30 mm).
cAMP signaling
Fmr1 KO andWTmale mice were given five (13/day, i.p.) injections. Exposure
was considered acute (SAL on days 1–4 and SAL or COC on day 5; 20 mg/kg)
or chronic (SAL or COC on days 1–5; 20 mg/kg). Mice were sacrificed 20 min
after the last dose.Neuron 82, 645–658, May 7, 2014 ª2014 Elsevier Inc. 655
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Equal amounts of protein were separated by SDS-PAGE and transferred to
polyvinylidene fluoride membranes, which were blocked, rinsed, and incu-
bated with primary and horseradish-peroxidase-conjugated secondary anti-
bodies. Membranes were washed and developed using standard enhanced
chemiluminescence and X-ray film.
Quantitative Real-Time PCR
RNA isolation, reverse transcription, and quantitative real-time PCR were
carried out as described elsewhere (Hale et al., 2011). Fmr1 expression was
determined by running reactions of 5 ng of cDNA and is expressed as fold
change relative to GAPDH.
Dendritic Analyses
Unobstructed MSNs of the NAc core or shell (two to six per subregion
per mouse) were traced bilaterally (403) using Neurolucida software (MBF
Bioscience). Spines were counted (1003) from a single third order, or higher,
complete terminal tip (R20 mM) and categorized by type. Quantitative assess-
ment was performed using NeuroExplorer software (MBF Bioscience).
Immunohistochemistry/Injection Placement
Sections were blocked and incubated with primary and secondary antibodies.
Sections were counterstained, mounted, and assessed for placement. Mice
with green fluorescent protein (GFP) staining outside the NAc, or with little or
no GFP staining in the NAc, were removed.
Electrophysiology
Mice received daily injections (two SAL + five SAL or COC; 15 mg/kg). Twenty-
four hours after the last dose, sagittal slices containing the NAc shell were
prepared as described elsewhere (Thomas et al., 2001). Briefly, MSNs were
identified by typical morphology and voltage clamped at 80 mV. Recordings
were performed in the presence of picrotoxin (100 mM) to block GABAA-medi-
ated inhibitory postsynaptic currents. To assess excitatory synaptic neuro-
transmission, mEPSCs (amplitudes and frequencies) were collected in the
presence of 0.7 mM lidocaine. For AMPA/NMDA ratio measurements, NAc
afferents were stimulated to evoke AMPAR and NMDAR EPSCs in MSNs
voltage clamped at +40 mv. The peak amplitude of AMPAR-mediated EPSCs
was divided by the peak amplitude of NMDAR-mediated EPSCs. For PPR, two
EPSC amplitudes were generated at 80 mV (interstimulus intervals: 20, 50,
100, and 200 ms). The peak amplitude of the second EPSC (P2) was divided
by the peak of the first (P1) to generate the paired-pulse ratio (P2/P1).
Data Analysis
Statistical analyses/results are listed in Table S1. Sensitization, stereotypy,
and dendritic spine density data were initially analyzed by two- or three-way
repeated-measures (RM) analyses of variance (ANOVAs) for each experi-
ment/NAc subregion, as appropriate. Within-subjects variables were day
and spine type, respectively; and between-subjects variables were genotype
alone or Genotype 3 Treatment. Dendritic branch number and length were
analyzed by separate three-way RM ANOVAs for each NAc subregion, with
genotype and treatment as between-subjects variables and branch order as
the within-subjects variable. CPP scores were analyzed by Independent
Samples T test or two-way ANOVA, as appropriate. Overall spine density
and P-Ser845 data were each analyzed by two-way ANOVAs. Significant inter-
actions were followed by post hoc analyses or multivariate (MV)/univariate
ANOVAs, as noted, to determine simple main effects. Locomotor challenge
time points were analyzed by MV ANOVAs. All statistics were performed using
either SPSS or GraphPad Prism software, remaining consistent within data
set. Significance was set at alpha = 0.05. The Greenhouse-Geisser correction
was applied whenever the data violated the sphericity assumption.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and one table and can be found with this article online at http://
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